Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bryan P Schneider

Showing results (51-60 of 119) with videos related to

Pageof 12
Sort By:
Cancer|October 16, 2012
Survival in patients with metastatic recurrent breast cancer after adjuvant chemotherapy: little evidence of improvement over the past 30 yearsAmye J Tevaarwerk, Robert J Gray, Bryan P Schneider, et al.
Contemporary Clinical Trials|October 10, 2020
Protocol of a randomized trial of acceptance and commitment therapy for fatigue interference in metastatic breast cancerCatherine E Mosher, Ellen Krueger, Adam T Hirsh, et al.
Cancer|May 30, 2026
Impact of patient-reported taxane-induced peripheral neuropathy on dose reductions or worsening quality of life in Black women with breast cancer: Analysis from ECOG-ACRIN EAZ171Tarah J Ballinger, Fengmin Zhao, Guanglong Jiang, et al.
Oncotarget|October 13, 2016
Charcot-Marie-Tooth gene, SBF2, associated with taxane-induced peripheral neuropathy in African AmericansBryan P Schneider, Dongbing Lai, Fei Shen, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|February 28, 2025
Elevated Tumor Mutation Burden in Cancer Patients with Underlying HIV Infection: Data from the Oncology Research Information Exchange Network (ORIEN)Anna E Coghill, Nathan Van Bibber, Robert A Baiocchi, et al.
Clinical Pharmacology and Therapeutics|January 10, 2025
Return of Clinically Actionable Pharmacogenetic Results From Molecular Tumor Board DNA Sequencing Data: Workflow and Estimated CostsHyunwoo Koo, Tayler B Smith, John T Callaghan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 4, 2015
Cerebral Perfusion and Gray Matter Changes Associated With Chemotherapy-Induced Peripheral NeuropathyKelly N H Nudelman, Brenna C McDonald, Yang Wang, et al.
Science Translational Medicine|February 11, 2021
Targeted immunotherapy for HER2-low breast cancer with 17p lossYujing Li, Yifan Sun, Michael Kulke, et al.
Frontiers in Cardiovascular Medicine|January 2, 2023
Association of QT interval-prolonging drugs with clinical trial eligibility in patients with advanced cancerElizabeth J Rowe, Tyler Shugg, Reynold C Ly, et al.
Scientific Reports|January 10, 2024
Molecular and clinical effects of aromatase inhibitor therapy on skeletal muscle function in early-stage breast cancerTara A Seibert, Lei Shi, Sandra Althouse, et al.
Pageof 12

Showing results (51-60 of 119) with videos related to

Sort By:
Pageof 12
Cancer|October 16, 2012
Survival in patients with metastatic recurrent breast cancer after adjuvant chemotherapy: little evidence of improvement over the past 30 yearsAmye J Tevaarwerk, Robert J Gray, Bryan P Schneider, et al.
Contemporary Clinical Trials|October 10, 2020
Protocol of a randomized trial of acceptance and commitment therapy for fatigue interference in metastatic breast cancerCatherine E Mosher, Ellen Krueger, Adam T Hirsh, et al.
Cancer|May 30, 2026
Impact of patient-reported taxane-induced peripheral neuropathy on dose reductions or worsening quality of life in Black women with breast cancer: Analysis from ECOG-ACRIN EAZ171Tarah J Ballinger, Fengmin Zhao, Guanglong Jiang, et al.
Oncotarget|October 13, 2016
Charcot-Marie-Tooth gene, SBF2, associated with taxane-induced peripheral neuropathy in African AmericansBryan P Schneider, Dongbing Lai, Fei Shen, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|February 28, 2025
Elevated Tumor Mutation Burden in Cancer Patients with Underlying HIV Infection: Data from the Oncology Research Information Exchange Network (ORIEN)Anna E Coghill, Nathan Van Bibber, Robert A Baiocchi, et al.
Clinical Pharmacology and Therapeutics|January 10, 2025
Return of Clinically Actionable Pharmacogenetic Results From Molecular Tumor Board DNA Sequencing Data: Workflow and Estimated CostsHyunwoo Koo, Tayler B Smith, John T Callaghan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 4, 2015
Cerebral Perfusion and Gray Matter Changes Associated With Chemotherapy-Induced Peripheral NeuropathyKelly N H Nudelman, Brenna C McDonald, Yang Wang, et al.
Science Translational Medicine|February 11, 2021
Targeted immunotherapy for HER2-low breast cancer with 17p lossYujing Li, Yifan Sun, Michael Kulke, et al.
Frontiers in Cardiovascular Medicine|January 2, 2023
Association of QT interval-prolonging drugs with clinical trial eligibility in patients with advanced cancerElizabeth J Rowe, Tyler Shugg, Reynold C Ly, et al.
Scientific Reports|January 10, 2024
Molecular and clinical effects of aromatase inhibitor therapy on skeletal muscle function in early-stage breast cancerTara A Seibert, Lei Shi, Sandra Althouse, et al.
Pageof 12